US20030118645A1
(en)
*
|
1998-04-29 |
2003-06-26 |
Pather S. Indiran |
Pharmaceutical compositions for rectal and vaginal administration
|
US20030091629A1
(en)
*
|
1998-03-27 |
2003-05-15 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US6974590B2
(en)
|
1998-03-27 |
2005-12-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
SE9803240D0
(sv)
*
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
ES2374717T3
(es)
|
1999-10-29 |
2012-02-21 |
Euro-Celtique S.A. |
Formulaciones de hidrocodona de liberación controlada.
|
IT1318618B1
(it)
*
|
2000-07-10 |
2003-08-27 |
A C R Applied Coating Res S A |
Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
|
AU2001281746C1
(en)
|
2000-07-31 |
2010-09-09 |
ISTITUTO GENTILI S.r.l. |
Fentanyl composition for nasal administration
|
WO2002036099A1
(en)
|
2000-10-30 |
2002-05-10 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
EP1418862A4
(en)
*
|
2001-06-29 |
2010-06-09 |
Leon J Lewandowski |
INDIVIDUALIZED SEARCH THERAPY
|
FR2827517B1
(fr)
*
|
2001-07-23 |
2003-10-24 |
Bioalliance Pharma |
Systemes therapeutiques bioadhesifs a liberation prolongee
|
ATE358275T1
(de)
*
|
2001-11-16 |
2007-04-15 |
Randox Lab Ltd |
Verfahren und kit zum nachweis, oder zum quantifizieren von, metaboliten von fentanyl und metaboliten von fentanyl analoga
|
GB0217056D0
(en)
*
|
2002-07-23 |
2002-08-28 |
Ass Octel |
Use
|
GB0300531D0
(en)
|
2003-01-10 |
2003-02-12 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical compositions
|
EP1587514B3
(en)
*
|
2003-01-31 |
2011-06-22 |
Orexo AB |
A rapid-acting pharmaceutical composition
|
MXPA05009602A
(es)
*
|
2003-03-11 |
2005-11-08 |
Arakis Ltd |
Composiciones novedosas.
|
JP5137286B2
(ja)
|
2003-06-10 |
2013-02-06 |
帝國製薬株式会社 |
フェンタニル含有口腔粘膜貼付剤
|
GB0315632D0
(en)
|
2003-07-04 |
2003-08-13 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical formulations
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
EP1708685B1
(en)
*
|
2003-12-31 |
2011-03-09 |
Cima Labs Inc. |
Effervescent oral opiate dosage forms and methods of administering oxycodone
|
EA010826B1
(ru)
*
|
2003-12-31 |
2008-12-30 |
Сайма Лэбс Инк. |
Лекарственная форма фентанила для перорального применения, способ ее получения и способы лечения
|
WO2005065317A2
(en)
|
2003-12-31 |
2005-07-21 |
Cima Labs Inc. |
Effervescent oral fentanyl dosage form
|
KR20070030178A
(ko)
*
|
2004-02-17 |
2007-03-15 |
트랜스오랄 파마슈티칼스, 인코포레이티드 |
구강 점막을 가로지르는 수면제 전달용 조성물 및 이의사용 방법
|
GB0423800D0
(en)
|
2004-10-27 |
2004-12-01 |
Orexo Ab |
New pharmaceutical formulations
|
FR2883179B1
(fr)
*
|
2005-03-18 |
2009-04-17 |
Ethypharm Sa |
Comprime enrobe
|
JP2008534564A
(ja)
*
|
2005-03-28 |
2008-08-28 |
オレクソ・アクチエボラゲット |
痛みの治療に有用な新しい製薬組成物
|
US20070287740A1
(en)
*
|
2005-05-25 |
2007-12-13 |
Transcept Pharmaceuticals, Inc. |
Compositions and methods of treating middle-of-the night insomnia
|
US20070225322A1
(en)
*
|
2005-05-25 |
2007-09-27 |
Transoral Pharmaceuticals, Inc. |
Compositions and methods for treating middle-of-the night insomnia
|
US8242131B2
(en)
*
|
2005-05-25 |
2012-08-14 |
Transcept Pharmaceuticals, Inc. |
Methods of treating middle-of-the-night insomnia
|
CN101330903B
(zh)
*
|
2005-12-13 |
2015-07-08 |
生物递送科学国际公司 |
防滥用的经黏膜给药装置
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US9066847B2
(en)
*
|
2007-01-05 |
2015-06-30 |
Aceirx Pharmaceuticals, Inc. |
Storage and dispensing devices for administration of oral transmucosal dosage forms
|
US8202535B2
(en)
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
US8535714B2
(en)
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
CN101378732A
(zh)
*
|
2006-01-06 |
2009-03-04 |
阿塞尔Rx制药有限公司 |
用于口腔经粘膜递送的生物粘附药物制剂
|
US8357114B2
(en)
|
2006-01-06 |
2013-01-22 |
Acelrx Pharmaceuticals, Inc. |
Drug dispensing device with flexible push rod
|
US9289583B2
(en)
|
2006-01-06 |
2016-03-22 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
US8252328B2
(en)
*
|
2006-01-06 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8252329B2
(en)
*
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8753308B2
(en)
|
2006-01-06 |
2014-06-17 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
DK1976521T3
(en)
|
2006-01-25 |
2015-04-27 |
Insys Therapeutics Inc |
Sublingual fentanyl spray
|
EP1837020A1
(en)
|
2006-03-24 |
2007-09-26 |
Bioalliance Pharma |
Mucosal bioadhesive slow release carrier for delivering active principles
|
US20070260491A1
(en)
*
|
2006-05-08 |
2007-11-08 |
Pamela Palmer |
System for delivery and monitoring of administration of controlled substances
|
US20070286900A1
(en)
*
|
2006-06-09 |
2007-12-13 |
Catherine Herry |
Low dose tablets of opioid analgesics and preparation process
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
US20070299687A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Pamela Palmer |
Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
|
KR101230804B1
(ko)
|
2006-07-21 |
2013-02-08 |
바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 |
향상된 흡수를 갖는 경점막 전달 장치
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
US20080090874A1
(en)
*
|
2006-09-20 |
2008-04-17 |
Messina John C Jr |
Treatment of breakthrough pain in patients suffering from chronic low back pain
|
FR2907680B1
(fr)
*
|
2006-10-27 |
2012-12-28 |
Scras |
Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux
|
WO2008068471A1
(en)
|
2006-12-04 |
2008-06-12 |
Orexo Ab |
New non-abusable pharmaceutical composition comprising opioids
|
JP2010518086A
(ja)
|
2007-02-09 |
2010-05-27 |
デュレクト コーポレーション |
スフェンタニルおよびナロキソンを含む経口腔投与製剤
|
US8173666B2
(en)
|
2007-03-12 |
2012-05-08 |
Nektar Therapeutics |
Oligomer-opioid agonist conjugates
|
US10512644B2
(en)
|
2007-03-12 |
2019-12-24 |
Inheris Pharmaceuticals, Inc. |
Oligomer-opioid agonist conjugates
|
US20080287494A1
(en)
*
|
2007-04-24 |
2008-11-20 |
Cephalon, Inc. |
Transmucosal treatment methods in patients with mucositis
|
CN101686931B
(zh)
*
|
2007-06-06 |
2013-06-19 |
巴斯夫欧洲公司 |
用于制备可咀嚼片剂和锭剂的药物配制剂
|
PL2180844T3
(pl)
|
2007-08-02 |
2018-07-31 |
Insys Development Company, Inc. |
Rozpylacz podjęzykowy z fentanylem
|
US8945592B2
(en)
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
EP2295046B1
(de)
*
|
2009-09-14 |
2012-12-19 |
Acino AG |
Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
|
US8901113B2
(en)
|
2009-09-30 |
2014-12-02 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
ES2712989T3
(es)
|
2009-10-30 |
2019-05-17 |
Ix Biopharma Ltd |
Forma de dosificación sólida de disolución rápida
|
EP2568977A1
(en)
|
2010-05-11 |
2013-03-20 |
Cima Labs Inc. |
Alcohol-resistant metoprolol-containing extended- release oral dosage forms
|
US20120183580A1
(en)
*
|
2011-01-13 |
2012-07-19 |
Theralpha |
Analgesic Composition for Transbuccal Administration
|
KR101944367B1
(ko)
|
2011-08-18 |
2019-01-31 |
바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 |
부프레노르핀 운반용 약물남용 억제 점막 부착 장치
|
EP3939569A1
(en)
|
2011-09-19 |
2022-01-19 |
Orexo AB |
New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
DE102012006396A1
(de)
|
2012-03-29 |
2013-10-02 |
Willy Rüsch GmbH |
Tracheostomietubus
|
BR112014027213A8
(pt)
|
2012-05-02 |
2018-01-16 |
Orexo Ab |
nova composição de alfentanil para o tratamento de dor aguda
|
AU2013352162B2
(en)
|
2012-11-30 |
2018-08-16 |
Acura Pharmaceuticals, Inc. |
Self-regulated release of active pharmaceutical ingredient
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
RU2733468C2
(ru)
*
|
2014-02-07 |
2020-10-01 |
Сентар Фармасьютикалс, Инк. |
Полностью натуральные нетоксичные сублингвальные системы доставки лекарственных средств
|
US20160144528A1
(en)
|
2014-11-25 |
2016-05-26 |
Biodelivery Sciences International, Inc. |
Patch devices, methods and apparatus for forming, and testing pharmaceutical agent delivery patch devices
|
WO2017040607A1
(en)
|
2015-08-31 |
2017-03-09 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
EP3965733A4
(en)
|
2019-05-07 |
2023-01-11 |
Clexio Biosciences Ltd. |
ABUSE DETERRENT DOSAGE FORMS CONTAINING ESKETAMINE
|
US20220062200A1
(en)
|
2019-05-07 |
2022-03-03 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|